Page last updated: 2024-11-06

benzathine cloxacillin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Benzathine cloxacillin is a penicillin-based antibiotic used to treat bacterial infections. It is a long-acting formulation that is administered by intramuscular injection. The compound is a salt of cloxacillin with benzathine, which acts to increase the duration of action. Cloxacillin is a penicillinase-resistant antibiotic, meaning it is effective against bacteria that produce the enzyme penicillinase, which can inactivate penicillin. Benzathine cloxacillin is primarily used to treat infections caused by staphylococcal bacteria, such as skin infections, pneumonia, and endocarditis. Research has shown that benzathine cloxacillin is effective in treating these infections and has a good safety profile. The compound is studied because it is a long-acting antibiotic that can provide effective treatment with a single injection. Its importance lies in its ability to treat resistant bacterial infections that may be difficult to manage with other antibiotics.'

benzathine cloxacillin: Orbenin D.C. contains 500 mg of benzathine cloxacillin [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID64706
CHEMBL ID3989531
SCHEMBL ID150744
MeSH IDM0049364

Synonyms (30)

Synonym
cloxacillin benzathine
benzathine cloxacillin
cloxacillin benzathine (usp)
D03571
cloxacillin, n,n'-dibenzylethylendiamin-salz
unii-ac79l7pv2g
ac79l7pv2g ,
(2s,5r,6r)-6-(3-(o-chlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid compound with n,n'-dibenzylethylenediamine (2:1)
cloxacillin benzathine [usp]
einecs 245-855-2
cloxacillin benzathine salt
cloxacillin benzathine [green book]
cloxacillin benzathine [mart.]
cloxacillin benzathine [usp monograph]
cloxacillin benzathine salt [mi]
cloxacillin benzathine [usp-rs]
AKOS015896300
SCHEMBL150744
CHEMBL3989531
Q27122555
DTXSID101020014 ,
(2s,5r,6r)-6-[[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;n,n'-dibenzylethane-1,2-diamine
cloxacillin benzathine (usp monograph)
dtxcid201477864
dry-clox
orbenin dc
cloxacillin benzathine (usp-rs)
dry-clox intramammary infusion
cloxacillin benzathine (mart.)
orbenin-dc

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" For the IV pharmacokinetic phase, sodium cloxacillin was administered at dosage of 10 mg/kg of body weight to male Holstein calves (n = 6, weighing 146 to 170 kg), and serum concentration of cloxacillin was measured thereafter for 10 hours."( Ocular and serum disposition kinetics of cloxacillin after topical administration of benzathine cloxacillin and intravenous administration of sodium cloxacillin to calves.
Baggot, JD; Daigneault, J; George, LW, 1990
)
0.5
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
benzathine(2+) salt
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (38.89)18.7374
1990's5 (27.78)18.2507
2000's2 (11.11)29.6817
2010's3 (16.67)24.3611
2020's1 (5.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.41 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index4.38 (4.65)
Search Engine Demand Index36.32 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (15.79%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (84.21%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]